We previously elucidated an important role for gangliosides in renal cell carcinoma-mediated T lymphocyte apoptosis, although the mechanism by which they mediated lymphocyte death remained unclear. Here, we show that when added in purified form, GD3 is internalized by activated T cells, initiating a series of proapoptotic events, including the induction of reactive oxygen species (ROS), an enhancement of p53 and Bax accumulation, an increase in mitochondrial permeability, cytochrome c release, and the activation of caspase-9. GD3-induced apoptosis of activated T cells was dose dependent and inhibitable by pretreating the lymphocytes with N-acetylcysteine, cyclosporin A, or bongkrekic acid, emphasizing the essential role of ROS and mitochondrial permeability to the process. Ganglioside-induced T-cell killing was associated with the caspase-dependent degradation of nuclear factor-KB-inducible, antiapoptotic proteins, including RelA; this suggests that their loss is initiated only after the cascade is activated and that their disappearance amplifies but not triggers GD3 susceptibility. Resting T cells did not internalize appreciable levels of GD3 and did not undergo any of the proapoptotic changes that characterize activated T lymphocytes exposed to the ganglioside. RelA overexpression endows Jurkat cells with resistance to GD3-mediated apoptosis, verifying the role of the intact transcription factor in mediating protection from the ganglioside. [Cancer Res 2009;69(7):3095-104] 
Introduction
Evidence accumulated by our laboratory over the last several years has increasingly implicated gangliosides as being soluble tumor-derived factors that contribute significantly to T-cell apoptosis (1) (2) (3) (4) (5) . Gangliosides are structurally diverse acidic glycosphingolipids that are present in the outer leaflet of plasma membranes (6) and consist of a sialic acid-containing carbohydrate component attached to ceramide. Many tumors exhibit enhanced synthesis of select gangliosides, some of which are shed into the tumor microenvironment (7, 8) . Malignant melanomas and neuroblastomas overexpress GD3, GD2, and GM2, whereas renal cell carcinomas (RCC) were reported to display increased levels of GD1a, GM1, and GM2 compared with cells of the normal kidney (9) . Some tumor-derived gangliosides inhibit specific aspects of the immune response and thereby contribute to tumor formation and progression (10) (11) (12) (13) (14) (15) . Because neuraminidase abrogated the apoptotic effects that RCC supernatants have on T cells, we hypothesized that gangliosides were involved in RCC-mediated immune dysfunction (16) , a finding later confirmed by both the capacity of the ganglioside synthesis inhibitor 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol (PPPP) to abrogate RCC-mediated killing of cocultured T lymphocytes (2) and the ability of tumor necrosis factor a (TNFa) treatment of RCC lines to coordinately enhance their ganglioside accumulation and apoptogenicity for coincubated T cells (3) .
Our present work focuses on the mechanism by which gangliosides induce T-cell apoptosis. Current evidence implies that gangliosides mediate their proapoptotic effects by directly activating the intrinsic apoptotic pathway. In separate reports, Garcia-Ruiz and colleagues (17) and Rippo and colleagues (18) showed that the ganglioside GD3 could stimulate a burst of reactive oxygen species (ROS) and mitochondrial permeability in purified mitochondria, leading to the release of apoptogenic factors such as cytochrome c and apoptosis-inducing factor (AIF). Later studies showed that mitochondria are targeted even when intact cells are exposed to gangliosides, as GD3-treated hepatocytes underwent apoptosis in association with ROS production, mitochondrial permeability transition (MPT), cytochrome c release, and activation of caspase-9 (19, 20) .
The means by which tumor-derived gangliosides stimulate the apoptosis of T cells remains undefined, however. Garcia-Ruiz and colleagues showed that in response to TNFa, endogenous GD3 redistributes from the outer leaflet of hepatocyte membranes to mitochondria via Rab5-and Rab7-positive endosomes, where it induces the same series of proapoptotic events observed when isolated mitochondria are treated with the same ganglioside (20) . Studies pertaining to ganglioside transport in Niemann-Pick disease indicate that even exogenous gangliosides can be internalized and targeted to the Golgi complex within Rabexpressing vesicles (21) , potentially localizing to the mitochondria where they can induce toxic levels of ROS in glutathione-depleted cells, as described previously for the transported endogenous gangliosides (20) . The notion that exogenous gangliosides may also stimulate T-cell apoptosis in a mitochondrial-dependent manner is suggested by the ability of the Bcl-2 transgene to protect CEM lymphoma cells from GD3-induced caspase-9 activation and death (18) . The experiments described below suggest that such a scenario may in fact be the mechanism by which GD3 kills T lymphocytes: we find that GD3 specifically induces the apoptosis of activated but not resting T cells. Our results indicate that activated T cells internalize abundant levels of exogenously administered GD3 within 90 minutes, causing ROS production, MPT, and cytochrome c release by 24 hours and apoptosis by 48 hours. GD3-mediated apoptosis additionally involves p53 stabilization and induction of Bax and is amplified by the caspase-dependent degradation of nuclear factor-nB (NF-nB)-inducible antiapoptotic proteins. Resting T cells, which fail to internalize appreciable levels of the ganglioside, do not undergo any of these proapoptotic changes within the time frame examined, thus explaining the comparative resistance of that lymphocyte population to GD3-mediated destruction.
Materials and Methods
Antibodies and reagents. Anti-Bcl-xL, anti-Bcl-2, anti-Ciap-2, anti-p53, anti-Bax, anti-RelA, and horseradish peroxidase (HRP)-conjugated donkey anti-goat IgG were from Santa Cruz Biotechnology. Anti-XIAP was from BD Transduction Laboratories, and anti-actin (AC-15) was from Novus Biologicals. Anti-procaspase-9 and procaspase-8 antibodies were from Oncogene Research Products, and anti-cytochrome c and anti-GD3 were from BD Pharmingen. HRP-conjugated sheep anti-mouse and donkey antirabbit secondary antibodies were from Amersham, and caspase inhibitor III, caspase-9 inhibitor II, and caspase-8 inhibitor I (IETD-CHO) were all obtained from Calbiochem. Anti-CD3 antibody (OKT3, Ortho Biotech) and anti-CD28 antibody (Becton Dickinson Immunocytometry Systems) were used for the stimulation of T lymphocytes. Human recombinant interleukin-2 (IL-2; CHIRON Corp.) was used at 20 units/mL to maintain the viability of activated T cells.
Cell (24) were derived and maintained as described previously. The caspase-9 dominant-negative Jurkat cell line was generated using a cDNA expression vector encoding the active site mutation cysteine-287 to alanine (25) . A wellcharacterized, long-term glioblastoma cell line, U87, was obtained courtesy of Dr. Michael Vogelbaum (Cleveland Clinic) and CCF52 was a short-term GBM line subcultured from a fresh glioma by our Brain Tumor Registry.
Immunofluorescence. Tumor cells were immunostained to assess GD3 expression levels. RCC tumor cells, NKE control cells, and glioblastoma cells were fixed, blocked, and stained with 2 Ag/mL anti-GD3 antibodies as described previously (5) . After washing, the cells were incubated with an Alexa Fluor 594-labeled secondary antibody (Molecular Probes), washed, and counterstained with 4 ¶,6-diamidino-2-phenylindole (DAPI) to visualize the nuclei.
Resting and activated T cells were also assessed for their capacity to internalize GD3. The lymphocytes were adhered to lysine-coated glass slides for 2 h at 4jC in complete medium, at which time the medium was replaced with a solution of 25 Ag/mL GD3 in plain RPMI 1640. Ganglioside was allowed to adhere to the cells for 1 h at 4jC, at which point the slides were moved to 37jC for the designated times before being fixed, permeabilized, and immunostained for GD3 expression as described above.
Isolation of T cells. T cells were isolated from the peripheral blood of healthy volunteers with informed consent, as described before (3). The T-cell isolation procedure yielded cells that were >95% positive for CD3 as defined by immunocytometry. T cells were stimulated with crosslinked anti-CD3 (OKT3) and anti-CD28 antibodies for 3 d (26) and were then transferred to fresh flasks for further expansion in the presence of 20 units/mL IL-2 before use.
Induction and analysis of peripheral blood T-cell apoptosis. Resting and/or activated T cells (1 Â 10 6 /mL) were cultured in the presence or absence of GD3 for specified times before being analyzed for gangliosideinduced apoptosis by staining the lymphocytes with Annexin V and 7-aminoactinomycin-D (7AAD; BD Pharmingen). Events were acquired on a multivariable FACScan, and analysis was done using quadrant software (CellQuest v3.3, Becton Dickinson). Lymphocytes were additionally stained with 4 ¶6 ¶-diamidoino-2-phenylindole (DAPI) and analyzed by fluorescent microscopy to assess the number of T cells with apoptotic nuclei in the GD3-treated or untreated cultures. In some experiments, cells were pretreated with an antioxidant [N-acetylcysteine (NAC), 10 mmol/L; Sigma-Aldrich] or with inhibitors of mitochondrial permeability [cyclosporin A (CsA) and bongkrekic acid (BA); Calbiochem] before their exposure to GD3 to assess the role of mitochondrial involvement in gangliosidemediated T-cell apoptosis. In other experiments, activated T cells were pretreated with 150 Amol/L of caspase-8 inhibitor I, caspase-9 inhibitor II, or the pan-caspase inhibitor III before ganglioside administration to assess the role of specific caspases in mediating GD3-induced lymphocyte killing.
Electrophoretic mobility shift assays. Resting and activated T cells were pretreated or not with 100 Ag/mL GD3 for 48 h before stimulating the lymphocytes for 0, 15, and 30 min with phorbol 12-myristate 13-acetate (PMA; 10 ng/mL) and ionomycin (0.750 Ag/mL), at which point nuclear extracts were isolated and prepared in binding reaction buffer, as previously described (13) . Oligonucleotide corresponding to the IL-2Ra (5 ¶-CAACGG-CAGGGGAATCTCCCTCTCCTT-3 ¶) was obtained from Qiagen Operon and used as a probe. Radiolabeled double-stranded oligonucleotides were prepared and labeled with [a-
32 P]dCTP and were used in binding reactions with 10 Ag of nuclear protein, as described previously. Samples were resolved on 6% polyacrylamide gels and were dried and analyzed as before (1) .
Protein extracts, Western blot analysis, and cytochrome c assays. Cell lysates were prepared and run on SDS-PAGE gels, transferred to nitrocellulose membranes, and probed with primary antibodies as described previously (1, 27) . The immunoreactive proteins were visualized using HRP-linked secondary antibodies and enhanced chemiluminescence (ECL Western blotting kit, Amersham). Cytochrome c assays were performed as before (4) .
Assessment of ROS and mitochondrial membrane potential. Measurement of intracellular ROS was as described previously (28) . Briefly, 3 Â 10 6 resting or activated peripheral blood T cells were cocultured with GD3 for 18 h before isolating the lymphocytes and incubating them for an additional hour with 10 Amol/L 5,6-carboxy-2 ¶,7 ¶-dichlorofluorescein diacetate (CM-H 2 DCFDA, Molecular Probes). Cells were analyzed flow cytometrically for DCFDA fluorescence using an excitation wavelength of 488 nm and an emission wavelength of 535 nm. For measuring mitochondrial membrane potentials (Dw m ), T cells were treated with GD3 for 18 h as described above before incubating the lymphocytes for an additional 15 min at 37jC in 500 AL of 40 nmol/L DiOC 6 . The cells were then analyzed immediately by fluorescence-activated cell sorting (FACS) analysis using an excitation wavelength of 488 nm and an emission wavelength of 530 nm (29) .
Statistical analysis. The Student's t test (paired two samples for mean or two samples using equal variances) was used to determine P using Microsoft Excel software (version 2003). SE was calculated from SD using Microsoft Excel software.
Results
GD3 induces T-cell apoptosis. GD3 was used as the prototypic ganglioside in these studies for multiple reasons: it is overexpressed in numerous tumors of neuroectodermal and epithelial origin, including RCC ( Fig. 1 ; ref. 30); it is associated with both tumor progression (31) and immunosuppression (32, 33) ; and unlike some species of gangliosides, it has already been observed to induce the apoptosis of multiple cell types (19, 20, (34) (35) (36) . Indeed, we now show that resting and activated T cells show the same relative susceptibilities to purified GD3 as they do to ganglioside-producing tumor cells ( Fig. 2A and B; refs. 3, 5) . When resting and 5-dayactivated T cells were treated in vitro with 100 Ag/mL GD3, f52% of the activated lymphocytes became apoptotic by 48 hours, as assessed by FACS analysis of Annexin V/7AAD-stained cells ( Fig. 2A and B). This was in stark contrast to the ganglioside-treated resting T cells, which remained mostly viable throughout the 72-hour period monitored. Other criteria were also used to gauge ganglioside-mediated T-cell damage. Viable cells can also be differentiated by DAPI staining, which reveals the nuclear fragmentation and nuclear membrane invagination that uniquely typify apoptotic cells. Although the percentage of activated, GD3-treated T cells with apoptotic nuclei per visual field significantly increased following 48 hours of culture, ganglioside-treated resting lymphocytes retained morphologically normal nuclei throughout this time frame (Fig. 2C ). Minimal killing of resting T cells was observed even at 200 Ag/mL GD3, again contrasting with activated cells, which showed progressively escalating levels of susceptibility to GD3 as the ganglioside concentration was increased from 25 to 100 Ag/mL (Fig. 2D) .
Activated but not resting T lymphocytes readily internalize exogenous GD3. To assess the possibility that T-cell apoptosis induced by exogenous GD3 might require its internalization and intracellular trafficking, resting and activated T cells were compared for their relative abilities to internalize exogenous GD3 over the course of 2 hours. Cells were adhered to lysine-coated glass slides before being treated or not with 25 Ag/mL GD3 for 30, 60, 90, or 120 minutes, at which points the cells were fixed, permeabilized, and stained with anti-GD3 antibodies. When intracellular GD3 staining was compared at each time point by fluorescent microscopy, it was apparent that, unlike the resting cells, which remained mostly GD3 negative through 60 minutes of treatment and showed only hints of positivity at 90 and 120 minutes, the activated T cells showed definite signs of GD3 internalization by 30 minutes, stained highly positive by 60 and 90 minutes, but had diminishing levels at 2 hours (Fig. 3A) . Interestingly, even when washed and incubated in medium following a 30-minute exposure to GD3, f40% of the activated T-cell population still became apoptotic by 48 hours (Fig. 3B) , suggesting that lymphocytes need not be continuously exposed to gangliosides for the molecules to mediate their toxic effects. To address the argument that activated T cells have highly ruffled membranes, which bind more ganglioside and hence only give the appearance of increased ganglioside internalization, FACS analysis and confocal microscopy were performed on GD3-treated resting and activated T cells that were permeabilized or not to discriminate between adherent and internalized ganglioside. There was comparable binding of anti-GD3 with nonpermeabilized resting and activated T cells, reflecting the fact that the ganglioside adhered equivalently to both. FACS analysis of permeabilized cells, however, revealed the extent to which resting and activated T cells differed in their capacities to internalize GD3. GD3-treated permeabilized and nonpermeabilized resting T cells stained equivalently with the anti-GD3 antibody, indicating that resting T cells did not internalize much ganglioside. This contrasted with the permeabilized, GD3-treated activated T cells, which stained GD3 positive with far greater intensity than either nonpermeabilized activated T cells or permeabilized resting T cells (Fig. 3C) . Similar results were obtained when the same cells were subjected to examination by confocal microscopy ( Supplementary Fig. S1 ).
ROS accumulation, mitochondrial permeability, and cytochrome c release occur in activated but not resting T cells following treatment with GD3. To determine which GD3-induced proapoptotic events are differentially induced in activated and resting T cells, thereby explaining the differential susceptibility of those two populations to ganglioside-mediated death, lymphocytes were treated with 100 Ag/mL GD3 before being analyzed for various parameters of apoptosis over the course of 72 hours. DCFDA fluorescence revealed that the GD3-treated, activated T-cell population generated elevated levels of ROS that were readily detectable by FACS within 24 hours (Fig. 4A ). This contrasted with our findings for resting T cells, which, consistent with their decreased sensitivity to GD3-induced apoptosis and their only minimal capacity to internalize ganglioside, did not produce measurable levels of ROS within the same time frame (Fig. 4A ). When DiOC 6 fluorescence was used as a measure of increased mitochondrial permeability in response to GD3, the activated T cells were found to have progressed beyond ROS production to this advanced state by 48 hours after ganglioside treatment (Fig. 4B) . Western analysis revealed that the GD3 treatment had also induced the release of cytochrome c into the cytoplasm of the CD3/CD28-stimulated T cells, a requisite step for the direct activation of caspase-9 (Fig. 4C) . Resting T cells, on the other hand, were not stimulated to augmented ROS production by GD3 (Fig. 4A ) and did not undergo MPT or cytochrome c release in response to the ganglioside ( Fig. 4B and C) , consistent with the comparative resistance of the naive lymphocytes to GD3-mediated killing.
Antioxidants and inhibitors of mitochondrial permeability largely abrogate GD3-mediated apoptosis of activated T cells. Because GD3-induced reactive oxygen intermediates seem to act as mediators of T-cell apoptosis, we explored the capacity of NAC to protect the lymphocytes from ganglioside-induced death. When Figure 1 . GD3 is expressed by RCC and glioblastoma tumors and cell lines. Normal kidney epithelium, RCC cell lines SK-RC-45 and SK-RC-26, and the glioblastoma cell line U87 were grown on coverslips and were fixed and permeabilized before being immunostained with 2 Ag/mL anti-GD3 followed by an Alexa Fluor 594-labeled secondary antibody. Primary RCC and glioblastoma tumor cells were similarly stained following their isolation from biopsied patient samples, as described in Materials and Methods. Nuclei were revealed by DAPI staining.
activated T cells were treated with GD3 in the presence of 10 mmol/L NAC, lymphocyte killing was reduced by f50% (Fig. 4D) . The effects of BA and CsA on GD3-induced lymphocyte apoptosis were next determined, as each specifically inhibits a unique aspect of mitochondrial permeability. Only 12% to 15% of activated T cells underwent apoptosis when treated with GD3 in the presence of either CsA or BA, a significant reduction from the f52% of cells that were killed when GD3 was administered in medium alone (Fig. 4D) . The abilities of NAC, CsA, and BA to each inhibit GD3-mediated apoptosis of activated T cells collectively point to the integral role of ROS and mitochondria in mediating the ganglioside-induced effects.
Both caspase-8 and caspase-9 are required for optimal GD3-mediated apoptosis of activated T cells. Activated T cells were next treated with 100 Ag/mL GD3 for 72 hours in the presence or absence of either a pan-caspase inhibitor or specific inhibitors of caspase-8 or caspase-9 before being assessed for Annexin V/7AAD positivity. The pan-caspase inhibitor provided the greatest protection, decreasing GD3-mediated apoptosis of the treated cells 5-fold to f10% of the total population. The caspase-9 inhibitor was also extremely effective, as it reduced the killing from 52% to f22% (Fig. 5A) . The fact that the caspase-8 inhibitor also significantly reduced GD3-mediated killing of activated T cells (Fig. 5A ) was somewhat surprising because these and previous studies suggest that the initial insult occurs to the mitochondrion (17, 18, 20) . This result was supported, however, by experiments gauging the relative susceptibilities of wild-type, caspase-8-negative, and caspase-9-negative Jurkat cells to the ganglioside (Fig. 5B) . As compared with the 55% of wild-type Jurkat cells that underwent apoptosis following a 3-day exposure to GD3, both mutant lines were significantly protected, with killing of the caspase-8-negative and caspase-9-negative cells dropping to 25% and 17% of the ganglioside-exposed populations, respectively (Fig. 5B) . The dependence on both caspase-8 and caspase-9 for optimal GD3-mediated killing of activated T cells and Jurkat cells contrasts with results obtained using TPEN, a prototypic and Figure 2 . GD3 can induce the apoptosis of activated but not resting T cells. A, T cells were isolated from healthy volunteers and were activated or not with anti-CD3/CD28 for 5 d. Both lymphocyte populations were exposed to 100 Ag/mL GD3 for 24, 48, and 72 h and, at each time point, were assessed and compared for ganglioside-induced apoptosis by Annexin V/7AAD staining, as described in Materials and Methods. Columns, mean of six experiments; bars, SE. *, P < 0.005 versus preactivated T cells in medium alone. B, typical Annexin V/7AAD staining data obtained by flow cytometry, which was used to generate the results presented in A and in all subsequent experiments assessing T-cell apoptosis under various experimental conditions. C, resting and anti-CD3/CD28-activated T cells were treated or not with 100 Ag/mL GD3 for 72 h before being stained with DAPI to quantify apoptotic nuclei by fluorescent microscopy. D, resting and anti-CD3/CD28-activated T cells were treated or not with 25, 50, 100, or 200 Ag/mL of GD3 for 72 h before being assessed for ganglioside-induced apoptosis by Annexin V/7AAD staining, as described in Materials and Methods. Columns, mean of three experiments; bars, SE. *, P < 0.005; **, P < 0.05 versus untreated activated T cells. potent agonist of the mitochondrial pathway, which induced close to 75% of the activated T cells to undergo apoptosis (Fig. 5A) . Here, caspase-9 was observed to be of foremost importance to the response, with only a minimal requirement for caspase-8: whereas both the pan-caspase inhibitor and the caspase-9 inhibitor reduced TPEN-induced T-cell apoptosis from 72% of the cells to 20% and 30%, respectively, the caspase-8 inhibitor had only a negligible protective effect on TPEN-induced killing (Fig. 5A) .
GD3 treatment decreases the expression of NF-KBdependent, antiapoptotic proteins in activated but not resting T cells. We previously showed that RCC-mediated killing of cocultured activated T lymphocytes was associated with the depletion of antiapoptotic T-cell proteins by a mechanism that could be abrogated by pretreating the tumor cells with the ganglioside synthesis inhibitor PPPP (1, 23) . Here, we asked whether GD3 treatment alone would decrease antiapoptotic protein expression, and if so, whether the effect was limited to the GD3-susceptible, activated T-cell population. We found that in addition to activating caspase-8 and caspase-9 in the activated T cells, as evidenced by the depletion of their zymogens (Fig. 5C) , GD3 also mediated a dramatic and progressive decline in Bcl-2 and Bcl-xL expression levels (Fig. 5C ), findings deemed significant given the important contributions those proteins make to maintaining the integrity of mitochondrial membranes (37) . Ciap-2 and XIAP are also NF-nB-dependent antiapoptotic proteins that function by blocking the activity of effector caspases (38) and GD3 decreased these too from the elevated levels that characterize activated T cells (Fig. 5C) . Importantly, none of these protein modifications occurred in GD3-treated resting T cells, consistent with their resistance to ganglioside-induced apoptosis (Fig. 5C) .
A pan-caspase inhibitor abrogates GD3-mediated decreases in NF-KB-dependent, antiapoptotic protein expression but does not inhibit the induction of p53 or Bax. Because we observed that GD3-mediated apoptosis of activated T cells (Fig. 2 ) Figure 3 . Activated T cells internalize GD3 at a faster rate and in greater amounts than resting T cells. A, resting T cells isolated from a healthy donor were compared with 5-d anti-CD3/CD28-activated T cells for their capacity to internalize exogenously administered GD3. Cells were adhered onto lysine-coated slides for 2 h at 37jC and were cooled to 4jC before replacing the complete medium with a solution of 25 Ag/mL GD3 in plain RPMI 1640. The ganglioside was allowed to adhere to cells for 1 h at 4jC, at which point slides were washed briefly to remove nonadherent GD3, and then moved to 37jC for the designated times before being fixed, permeabilized, and immunostained with 2 Ag/mL anti-GD3 followed by an Alexa Fluor 594-labeled secondary antibody. B, 30 min of GD3 exposure can induce the apoptosis of activated T cells by 48 h. T cells were isolated from healthy volunteers and were activated or not with anti-CD3/CD28 for 5 d. Cells were either continuously exposed to 100 Ag/mL GD3 or had the ganglioside washed away and replaced with fresh medium after a 30-min treatment. Apoptosis of all treatment groups was measured and compared at 48 h by counting number of DAPI-stained, blebbed nuclei per 100 cells. Bars, SE. *, P < 0.005 versus activated T cells in medium alone. C, internalized GD3 cannot be visualized unless lymphocytes are permeabilized before immunostaining. Resting and activated T cells were exposed to 50 Ag/mL GD3 for 30 min and then were fixed and permeabilized or not before being stained with 2 Ag/mL anti-GD3 and an Alexa Fluor 488-labeled secondary antibody for analysis by flow cytometry.
was associated with GD3-induced ROS (Fig. 4A) , we next assessed the involvement of p53 in ganglioside-stimulated lymphocyte killing. Cytoplasmic lysates made from activated T cells treated or not with 100 Ag/mL GD3 for 48 hours were subjected to Western analysis using antibodies to p53 and Bax. We found that the ganglioside did in fact up-regulate both p53 and Bax (Fig. 5D ), results consistent with the capacity of the ganglioside to sequentially induce downstream ROS accumulation, increased mitochondrial permeability, cytochrome c release, and initiation of the caspase cascade. When GD3 treatment of activated T cells took place in the presence of a pan-caspase inhibitor, the gangliosidemediated loss of Bcl-xL, Ciap-2, and XIAP expression levels was abrogated, suggesting that the activation of caspases either directly or indirectly diminished the expression of those proteins (Fig. 5D) . The GD3-mediated inductions of p53 and Bax, on the other hand, were not prevented by the pan-caspase inhibitor, results expected of molecular events upstream of ganglioside-induced caspase activation (Fig. 5D) .
Previous studies from our laboratory showed that SK-RC-45 induced RelA degradation in cocultured, activated T cells by mechanism that was both tumor ganglioside and caspase dependent (1) . To assess the relative susceptibilities of resting and activated T cells to GD3-mediated proteolysis of RelA, Western analysis was performed on whole-cell lysates made from each population following a 48-hour exposure to the ganglioside. RelA levels in resting T cells were not altered by the ganglioside but dropped precipitously in GD3-treated activated T cells by a mechanism that was caspase dependent (Fig. 6A and B) , results paralleling those observed for the antiapoptotic proteins. Consistent findings were obtained when RelA activity in the GD3-treated cells was monitored by an electrophoretic mobility shift assay (EMSA). As compared with unstimulated cells, treatment of resting and activated T cells with PMA/ionomycin resulted in the translocation of RelA to the nucleus, as evidenced by its increased binding to an oligonucleotide encoding the kB element of the IL-2Ra gene (Fig. 6C) . A 48-hour pretreatment of the activated T cells with GD3 completely inhibited the PMA/ionomycin-induced nuclear translocation of RelA, however, although the ganglioside had no such effect on the resting cells (Fig. 6C) .
Overexpression of RelA protects Jurkat cells from GD3-induced apoptosis. The possibility that ganglioside-induced NF-nB degradation contributes to GD3-mediated T-cell apoptosis led us to ask whether overexpressing RelA would confer protection to GD3-treated Jurkat cells. A Jurkat cell clone permanently transfected with the PcDNA3/HA-RelA construct (1) was therefore compared with wild-type Jurkat cells for their susceptibility to GD3. Neither wild-type nor RelA-transfected Jurkat cells showed significant susceptibility to the ganglioside after 24 hours of treatment, although by 48 hours the RelA-overexpressing cells had a distinct survival advantage: 33% of wild-type Jurkat cells had succumbed to GD3, but only 12% of the RelA-transfected cells stained positive for Annexin V/7AAD (Fig. 6D) . The ability of the RelA transgene to inhibit GD3-mediated killing of Jurkat cells by 66% points to the importance of continuous RelA-induced antiapoptotic gene transcription in protecting T cells from ganglioside-induced apoptosis.
Discussion
Here, we show that GD3 can mediate the apoptosis of activated T cells by a mechanism involving enhanced production of ROS, p53, and Bax accumulation, the induction of mitochondrial permeability, the stimulation of cytochrome c release, and the activation of caspase-9, events all initiated and occurring sequentially following GD3 internalization by the lymphocytes. Resting T cells did not Figure 4 . GD3 induces ROS production, MPT, and cytochrome c release in activated but not resting T cells. T cells were isolated from healthy volunteers and were activated or not with anti-CD3/CD28 for 5 d. Cells were exposed to 100 Ag/mL GD3 over the course of 48 h, and at various time points, different parameters of GD3-induced proapoptotic effects were measured on each population. A, resting and activated Tcells exposed to GD3 for 24 h were treated with 2 Amol/L DCFDA for 15 min and were subjected to FACS analysis to assess ROS production, as measured by the increase in DCFDA fluorescence over medium controls. B, to detect the loss of mitochondrial potential following 48 h of exposure to GD3, resting and activated T cells were stained with 40 nmol/L of the mitochondrial potential-sensitive dye DiOC 6 for 15 min. The two populations were compared by FACS analysis for their decreased levels of DiOC 6 staining following exposure to GD3, which serves as a measure of their susceptibility to GD3-induced activation of MPT. C, resting and activated Tcells exposed to GD3 for 48 h were homogenized in mitochondrial isolation buffer, and supernatants were subjected to Western analysis using 30 Ag of protein/lane and antibodies to cytochrome c. Cells treated with the apoptogenic agent TPEN served as positive controls for cytochrome c release. Actin served as a loading control. D, activated Tcells were pretreated or not with the antioxidant NAC or the mitochondrial pathway inhibitors CsA or BA before being exposed to GD3 for 72 h and then measured for ganglioside-induced apoptosis by Annexin V/7AAD staining, as described in Materials and Methods. Columns, mean of three experiments; bars, SE. *, P < 0.005 versus medium alone.
readily internalize GD3 and were not observed to undergo any of the aforementioned proapoptotic changes in response to the ganglioside. The GD3-induced apoptosis of activated T cells was first detectable 48 hours after ganglioside treatment and was dose dependent, becoming evident at 25 Ag/mL, appreciable at 50 Ag/mL, and plateauing at 100 Ag/mL. Interestingly, unfractionated, tumor-derived gangliosides collectively induce T-cell apoptosis at even 7 Ag/mL, suggesting that the glycosphingolipids likely synergize to mediate appreciable lymphocyte death at much lower, more physiologically relevant concentrations in vivo (23). Bcl-xL, Ciap-2, and XIAP were degraded in the GD3-treated activated T cells by a mechanism that was caspase dependent, suggesting that although a deficiency of antiapoptotic proteins might have amplified GD3-induced T-cell apoptosis, their loss did not initiate the process. Previous studies performed in other cell types and on the purified organelles indicated that GD3 exerts its apoptogenic effects by acting directly on mitochondria. Our observation that activated T cells pretreated with NAC, CsA, or BA were able to resist GD3-induced apoptosis attested to a similar role for GD3-stimulated ROS production and mitochondrial permeability in mediating the death of intact lymphocytes as well.
Based on our results, it would seem that T-cell internalization of GD3 is requisite for the ganglioside to mediate its apoptotic effects: when assessed by both confocal microscopy and FACS analysis, it was only the activated T cells that internalized appreciable amounts of the ganglioside, which correlated with the unique susceptibility of that population to GD3-mediated killing. Although we are presently examining the itinerary of internalized gangliosides in T cells, there is precedence in other cell types for endogenous GD3 to be transported from the plasma membrane to mitochondria in response to apoptotic stimuli such as TNFa (20) , a molecule synthesized by activated but not resting T cells (5). Jurkat cells, and Jurkat cells rendered caspase-9 deficient following overexpression of a dominant-negative form of the enzyme were treated with GD3 for 72 h before being assessed for apoptosis by Annexin V staining, as described in Materials and Methods. Resting and activated T cells were treated or not with 100 Ag/mL GD3 for 24 and 48 h. Columns, mean of three experiments; bars, SE. *, P < 0.005 versus GD3-treated wild-type Jurkat cells. C, resting and activated T cells were treated or not with 100 Ag/mL GD3 for 24 and 48 h, at which point cytoplasmic lysates made from those cells were subjected to Western analysis using 20 Ag/protein/lane and antibodies to Ciap-2, XIAP, Bcl-xL, Bcl-2, procaspase-8, and procaspase-9. Actin was used as a loading control. D, resting and activated T cells were treated or not with 100 Ag/mL GD3 for 24 h in the presence or absence of a pan-caspase inhibitor, at which point cytoplasmic lysates made from those cells were subjected to Western analysis using 20 Ag/protein/lane and antibodies to p53, Bax, Bcl-xL, Ciap-2, and XIAP. Actin was used as a loading control.
Consistent with their common structural features, it is hypothesized that GD3, like ceramide, initiates the accumulation of toxic ROS by disrupting electron flow at complex III of the respiratory chain (17, 28) . Resulting oxidative stresses trigger conformational changes in inner mitochondrial membrane proteins, leading to MPT, cytochrome c release, activation of caspase-9, and the apoptosis observed in these ganglioside-treated cells (17) . A role for ROS in ganglioside-mediated apoptosis of activated T cells was shown by the ability of NAC to inhibit the killing by >50%. The capacity of both CsA and BA to reduce GD3-mediated apoptosis of activated T cells 3-to 5-fold from the levels observed with GD3 alone further underscored the important contribution of GD3-induced mitochondrial permeability to T-cell killing.
Associated with the GD3-mediated apoptosis of activated T cells was the augmented expression of p53 and Bax, the mitochondrial release of cytochrome c, and the activation of caspase-9. p53 is a transcription factor activated in response to cellular stresses and mediates its effects by inducing the de novo expression of growthinhibitory or proapoptotic molecules that prevent the proliferation of damaged or infected cells (39) . The protein is ordinarily short lived, being maintained at low levels by an inhibitor that restricts its transcription and promotes its degradation. When the cell perceives DNA damage or toxic ROS, however, p53 is stabilized, leading to the transcriptional activation of Bax, a proapoptotic Bcl-2 family member that forms the mitochondrial pores through which cytochrome c enters the cytoplasm to initiate the intrinsic pathway (39) . Consistent with our findings, Bharti and Singh (40) previously detected elevated p53 and Bax in murine bone marrow cells en route to an apoptotic cell death following a 24-hour treatment with purified T-cell lymphoma gangliosides. Although in our studies the pan-caspase inhibitor prevented GD3-mediated apoptosis, it could not abrogate the ganglioside-induced elevations of p53 or Bax expression, indicating that GD3-stimulated ROS and the sequential elevations in p53 and Bax are caspase-independent steps in the pathway to lymphocyte death.
Enhancing the GD3-mediated apoptosis of activated T cells was the ganglioside-induced depletion of several antiapoptotic proteins, including Ciap-2, XIAP, Bcl-xL, and Bcl-2. Ciap-2 and XIAP both abrogate apoptosis by directly binding and inhibiting caspases, whereas Bcl-xL and Bcl-2 control survival by inhibiting Bax and BAK, proapoptotic proteins that produce the mitochondrial pores that release cytochrome c, Smac/Diablo, and AIF (41) . The ability of the pan-caspase inhibitor to prevent Bcl-xL, Ciap-2, and XIAP loss during the GD3 treatment of activated T cells suggests that those proteins are stable until the caspase cascade is activated; so, although the depletion of antiapoptotic proteins during the course of apoptosis might amplify and/or hasten cell death, it is not the loss of those molecules that initially renders the lymphocytes susceptible to the ganglioside. The expression levels of the antiapoptotic proteins were not altered in GD3-treated resting Figure 6 . GD3 inhibits NF-nB activation in anti-CD3/CD28-stimulated T cells by a mechanism that involves inhibition of RelA expression. A, resting and 5-d anti-CD3/ CD28-activated T cells were treated or not for 48 h with 100 Ag/mL GD3, at which point whole-cell lysates made from those cells were subjected to Western analysis using 20 Ag/protein/lane and antibodies to RelA. Actin was used as a loading control. B, activated T cells were treated or not for 48 h with 100 Ag/mL GD3 in the presence or absence of a pan-caspase inhibitor, at which point whole-cell lysates made from those cells were subjected to Western analysis using 20 Ag/protein/lane and antibodies to RelA. Actin was used as a loading control. C, resting and activated T cells were treated or not for 48 h with 100 Ag/mL GD3, at which time the lymphocytes were stimulated for 0, 15, or 30 min with 10 ng/mL PMA and 0.75 Ag/mL ionomycin. Nuclear lysates prepared from the lymphocytes were then subjected to EMSA analysis as described in Materials and Methods using the NF-nB consensus site of the IL-2Ra promoter as probe. D, wild-type and RelA-transfected Jurkat cells were treated or not with GD3 for 24 and 48 h, at which times the lymphocytes were assessed for ganglioside-induced apoptosis by Annexin V/7AAD staining and FACS analysis, as described in Materials and Methods. Columns, mean of three experiments; bars, SE. *, P < 0.005 versus wild-type Jurkat cells treated with GD3 for 48 h. cells, however, consistent with the resistance of naive T lymphocytes to GD3-induced caspase activation.
There are multiple mechanisms by which GD3 might negatively regulate Bcl-xL, Ciap-2, and XIAP expression levels in a caspasedependent manner. Ganglioside-activated caspases might directly degrade them, or a protease downstream of activated caspases might be mediating the activity. It is also possible that only RelA is cleaved (1), thus inhibiting the transcription of these NF-nBdependent, antiapoptotic molecules; indeed, caspase inhibitors coincidentally rescued both RelA and the antiapoptotic proteins in GD3-treated T cells. Arguing for direct caspase-dependent proteolysis of Bcl-2 and Ciap-2 in GD3-treated activated T cells, however, was the long-term stability of those proteins in the presence of cycloheximide, suggesting that only inhibiting their synthesis would not affect their expression levels within a 24-hour time frame (data not shown). The degradation of RelA is ultimately critical for GD3-induced apoptosis, however, because RelA overexpression by Jurkat cells is protective.
Our interest in the mechanism by which GD3 induces the apoptosis of T cells stems in part from the role of tumor-derived gangliosides in mediating immune dysfunction, thereby facilitating the progressive growth of the tumors that produce them. We previously showed that the SK-RC-45 RCC line that overexpresses GD3 was much more effective at inducing apoptosis in activated T lymphocytes compared with resting T cells (3, 5) and also showed that one of the most apoptogenic high-performance liquid chromatography fractions of two glioma line-derived ganglioside preparations contains GD1a and GD3 (23) . This SK-RC-45-mediated killing was inhibitable by PPPP and hence dependent on its ganglioside production, and the fact that T-cell death was accompanied by mitochondrial permeability (4), cytochrome c release (2), and caspase-9 activation (2) collectively suggested that tumor-induced lymphocyte death occurred at least in part through the mitochondrial pathway. Precisely why the SK-RC-45 tumor line selectively killed activated but not resting T cells remained enigmatic, however, prompting this comparative study of the GD3-induced effects on both cell types. Although our results with GD3 cannot be generalized to all gangliosides, given the unique molecular characteristics that distinguish them, the effects of GD3 on activated and resting T cells mirror those induced by SK-RC-45: both selectively kill only activated T cells through the intrinsic pathway by a mechanism that has ROS accumulation at the apex, and proteolysis of antiapoptotic proteins as a means of amplifying the response. Because the proapoptotic events leading to the GD3-induced death of activated T cells are initiated by ganglioside internalization, it seems likely that the resistance of resting T lymphocytes to the apoptotic effects of the ganglioside is based on the only inefficient internalization of the molecule by those cells.
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